Intellectual Property Cases filed in Delaware
Cases 1 - 10 of 110
RSS Feed | View as table | Sort by last update
AbbVie Inc. v. Hetero USA, Inc. et al
as 1:2023cv01332
Plaintiff: AbbVie Inc.
Defendant: Hetero USA, Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Sandoz Inc.
as 1:2023cv01212
Plaintiff: AbbVie Inc.
Defendant: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ZS Pharma, Inc. et al v. Sandoz Inc.
as 1:2023cv01191
Plaintiff: ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP
Defendant: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma Inc. et al v. Lupin Ltd. et al We have downloadable decisions or orders for this case
as 1:2023cv00819
Plaintiff: Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Defendant: Lupin Ltd., Lupin Pharmaceuticals, Inc., Sandoz Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Janssen Pharmaceuticals, Inc. et al v. Sandoz Inc.
as 1:2023cv00597
Plaintiff: Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV
Defendant: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff: AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant: Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Array BioPharma Inc. v. Sandoz Inc.
as 1:2022cv01316
Counter Defendant: Array BioPharma Inc.
Counter Claimant: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Biogen Inc. et al v. Sandoz Inc. et al
as 1:2022cv01190
Counter Defendant: Biogen Inc. and Biogen MA Inc.
Defendant: Sandoz Inc., Sandoz GmbH, Sandoz International GmbH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Sandoz Inc. et al
as 1:2022cv01124
Plaintiff: Neurocrine Biosciences, Inc.
Defendant: Sandoz Inc., Sandoz AG, Sandoz International GmbH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ZS Pharma, Inc. et al v. Sandoz Inc.
as 1:2022cv01101
Plaintiff: ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP
Defendant: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?